MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac)

ETK Leonardi, EC Azmitia - Neuropsychopharmacology, 1994 -

Author(s): Efrain Azmitia

Focus: MDMA


Methylenedioxymethamphetamine (MDMA), a serotonin (5-HT) neurotoxin, has been shown to promote the release of serotonin (5-HT) and block its reuptake. The increased buildup of extracellular 5-HT should normally be degraded by monoamine oxidase (MAO). The effects …

Last updated: Jul 27, 2020